147:
95:
197:
70:
222:
172:
8:
17:
223:
198:
173:
148:
96:
71:
14:
105:Gylcopeptide/beta-lactam resistance
23:
24:
236:
132:Highly relevant recent research
13:
1:
7:
10:
241:
109:co-exis in S. aureus
80:Incomplete sentence
228:
227:
232:
213:2015-06-11 14:29
210:2014-06-30 18:12
188:2014-07-02 22:42
185:2011-01-16 22:43
163:2010-06-15 14:37
160:2010-06-15 07:07
138:2007-05-26 16:23
135:2007-05-26 16:23
115:2006-08-17 23:43
112:2006-08-17 23:43
86:2006-06-15 09:31
83:2006-06-15 09:31
61:2013-07-11 10:17
58:2006-06-13 02:15
26:
25:
18:User:ClueBot III
240:
239:
235:
234:
233:
231:
230:
229:
182:Needs attention
55:Amount of cases
22:
21:
20:
12:
11:
5:
238:
226:
225:
220:
217:
214:
211:
208:
205:
201:
200:
195:
192:
189:
186:
183:
180:
176:
175:
170:
167:
164:
161:
158:
155:
151:
150:
145:
142:
139:
136:
133:
130:
126:
125:
122:
119:
116:
113:
110:
103:
99:
98:
93:
90:
87:
84:
81:
78:
74:
73:
68:
65:
62:
59:
56:
53:
49:
48:
45:
42:
39:
36:
33:
30:
15:
9:
6:
4:
3:
2:
237:
224:
221:
218:
215:
212:
209:
207:VISA vs. VRSA
206:
203:
202:
199:
196:
193:
190:
187:
184:
181:
178:
177:
174:
171:
168:
165:
162:
159:
156:
153:
152:
149:
146:
143:
140:
137:
134:
131:
128:
127:
123:
120:
117:
114:
111:
108:
104:
101:
100:
97:
94:
91:
88:
85:
82:
79:
76:
75:
72:
69:
66:
63:
60:
57:
54:
51:
50:
46:
43:
40:
37:
34:
31:
28:
27:
19:
106:
35:Start Date
47:Archive
41:Comments
38:End Date
157:Picture
32:Header
29:Order
16:<
219:1624
144:2315
44:Size
194:660
169:880
121:541
107:can
92:219
67:973
124:]
216:3
204:7
191:3
179:6
166:2
154:5
141:1
129:4
118:1
102:3
89:1
77:2
64:2
52:1
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.